ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report

This is a report of 30 years old woman suffering from Crohn’s disease who had a good clinical response to Infliximab (Remicade) at first, but during the treatment after 5 months she lost response. After receiving Adalimumab (Humira) clinical remission was reached on the day 20. The case demonstrates...

Full description

Bibliographic Details
Main Authors: Ivaylo Vazharov, Hristo Bozov, Snezha Zlateva, Georgi Bonchev
Format: Article
Language:English
Published: Peytchinski Publishing 2016-12-01
Series:Journal of IMAB
Subjects:
Online Access:http://www.journal-imab-bg.org/issues-2016/issue4/JofIMAB-2016-22-4p1389-1391.pdf
_version_ 1818118830203863040
author Ivaylo Vazharov
Hristo Bozov
Snezha Zlateva
Georgi Bonchev
author_facet Ivaylo Vazharov
Hristo Bozov
Snezha Zlateva
Georgi Bonchev
author_sort Ivaylo Vazharov
collection DOAJ
description This is a report of 30 years old woman suffering from Crohn’s disease who had a good clinical response to Infliximab (Remicade) at first, but during the treatment after 5 months she lost response. After receiving Adalimumab (Humira) clinical remission was reached on the day 20. The case demonstrates rapid response to adalimumab in incidence of losing efficacy to another tumor necrotic factor - alpha (TNF- alpha) antagonist.
first_indexed 2024-12-11T05:00:32Z
format Article
id doaj.art-ac0bb11062114a6ab4f02eef0ead3777
institution Directory Open Access Journal
issn 1312-773X
language English
last_indexed 2024-12-11T05:00:32Z
publishDate 2016-12-01
publisher Peytchinski Publishing
record_format Article
series Journal of IMAB
spelling doaj.art-ac0bb11062114a6ab4f02eef0ead37772022-12-22T01:20:10ZengPeytchinski PublishingJournal of IMAB1312-773X2016-12-012241389139110.5272/jimab.2016224.1389ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case reportIvaylo Vazharov0Hristo Bozov1Snezha Zlateva2Georgi Bonchev3Clinic of Internal diseases, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic of Anaesthesiology, Marine and Intensive medicine, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Military Medical Academy, Bulgaria.Clinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Military Medical Academy, Bulgaria.This is a report of 30 years old woman suffering from Crohn’s disease who had a good clinical response to Infliximab (Remicade) at first, but during the treatment after 5 months she lost response. After receiving Adalimumab (Humira) clinical remission was reached on the day 20. The case demonstrates rapid response to adalimumab in incidence of losing efficacy to another tumor necrotic factor - alpha (TNF- alpha) antagonist.http://www.journal-imab-bg.org/issues-2016/issue4/JofIMAB-2016-22-4p1389-1391.pdfCrohn's diseaseTNF- alpha inhibitorsadalimumabinfliximab
spellingShingle Ivaylo Vazharov
Hristo Bozov
Snezha Zlateva
Georgi Bonchev
ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
Journal of IMAB
Crohn's disease
TNF- alpha inhibitors
adalimumab
infliximab
title ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
title_full ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
title_fullStr ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
title_full_unstemmed ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
title_short ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
title_sort adalimumab induction and maintaining remission for crohn s disease in patient who lost response to infliximab case report
topic Crohn's disease
TNF- alpha inhibitors
adalimumab
infliximab
url http://www.journal-imab-bg.org/issues-2016/issue4/JofIMAB-2016-22-4p1389-1391.pdf
work_keys_str_mv AT ivaylovazharov adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport
AT hristobozov adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport
AT snezhazlateva adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport
AT georgibonchev adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport